Prosecution Insights
Last updated: April 19, 2026

Neurimmune AG

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18269996 HUMAN ANTI-TAU ANTIBODIES VAN DRUFF, SYDNEY 1643 Non-Final OA Jun 28, 2023
17924496 COMBINATION THERAPY FOR TTR AMYLOIDOSIS HOWARD, ZACHARY C 1674 Non-Final OA Mar 06, 2023
17292107 PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL LEVIN, JOEL D 1633 Non-Final OA May 07, 2021

Managing Neurimmune AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month